Complete thoracoscopic S9 and/or S10 segmentectomy through a pulmonary ligament approach: a retrospective study.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
17 Apr 2023
Historique:
received: 24 10 2022
accepted: 03 04 2023
medline: 19 4 2023
entrez: 18 4 2023
pubmed: 19 4 2023
Statut: epublish

Résumé

The high resolution of computed tomography has found the pulmonary ligaments that consists of a double serous layer of visceral pleura, forms the intersegmental septum, and enters the lung parenchyma. This study aimed to investigate the clinical feasibility of thoracoscopic segmentectomy (TS) of the lateral basal segment (S9), posterior basal segment (S10), and both through the pulmonary ligament (PL). Between February 2009 and November 2021, 542 patients underwent segmentectomy for malignant lung tumors at Tokyo Women's Medical University Hospital (Tokyo, Japan). This study included 51 patients. Among them, 40 underwent a complete TS of the S9, S10, or both by the PL approach (PL group), and the remaining 11 by the interlobar fissure approach (IF group). Patients' characteristics did not significantly differ between the two groups. In the PL group, 34 underwent video-assisted thoracoscopic surgery (VATS), and 6 underwent robot-assisted thoracoscopic surgery. In the IF group, all 11 underwent VATS. Operation duration, estimated blood loss, and postoperative complication frequency were not significantly different between these groups, but the maximum tumor diameter showed a significant difference. Complete TS of the S9, S10, and both through the PL is a reasonable option for tumors located in such segments. This approach is a feasible option for performing TS.

Sections du résumé

BACKGROUND BACKGROUND
The high resolution of computed tomography has found the pulmonary ligaments that consists of a double serous layer of visceral pleura, forms the intersegmental septum, and enters the lung parenchyma. This study aimed to investigate the clinical feasibility of thoracoscopic segmentectomy (TS) of the lateral basal segment (S9), posterior basal segment (S10), and both through the pulmonary ligament (PL).
METHODS METHODS
Between February 2009 and November 2021, 542 patients underwent segmentectomy for malignant lung tumors at Tokyo Women's Medical University Hospital (Tokyo, Japan). This study included 51 patients. Among them, 40 underwent a complete TS of the S9, S10, or both by the PL approach (PL group), and the remaining 11 by the interlobar fissure approach (IF group).
RESULTS RESULTS
Patients' characteristics did not significantly differ between the two groups. In the PL group, 34 underwent video-assisted thoracoscopic surgery (VATS), and 6 underwent robot-assisted thoracoscopic surgery. In the IF group, all 11 underwent VATS. Operation duration, estimated blood loss, and postoperative complication frequency were not significantly different between these groups, but the maximum tumor diameter showed a significant difference.
CONCLUSIONS CONCLUSIONS
Complete TS of the S9, S10, and both through the PL is a reasonable option for tumors located in such segments. This approach is a feasible option for performing TS.

Identifiants

pubmed: 37069664
doi: 10.1186/s13019-023-02256-8
pii: 10.1186/s13019-023-02256-8
pmc: PMC10111718
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150

Informations de copyright

© 2023. The Author(s).

Références

J Thorac Cardiovasc Surg. 2011 Mar;141(3):678-82
pubmed: 20884021
J Thorac Cardiovasc Surg. 2020 Dec;160(6):1586-1594
pubmed: 32111428
Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Oct 20;29(4):527-535
pubmed: 35096451
Asian J Endosc Surg. 2013 May;6(2):110-5
pubmed: 23323687
J Med Case Rep. 2021 Apr 25;15(1):196
pubmed: 33894773
Ann Thorac Surg. 2019 Nov;108(5):1543-1550
pubmed: 31302085
J Thorac Cardiovasc Surg. 2011 Jul;142(1):243-4
pubmed: 21683850
J Thorac Cardiovasc Surg. 2015 Mar;149(3):937-9
pubmed: 25467374
Eur J Cardiothorac Surg. 2012 May;41(5):1098-103
pubmed: 22219443
Ann Thorac Surg. 2012 Sep;94(3):929-34
pubmed: 22748642
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Radiology. 1992 Nov;185(2):389-93
pubmed: 1410343
Eur J Cardiothorac Surg. 2019 Mar 1;55(3):427-433
pubmed: 30325403
Surg Today. 2019 Oct;49(10):795-802
pubmed: 30859310
Lancet. 2022 Apr 23;399(10335):1607-1617
pubmed: 35461558
Thorac Cardiovasc Surg. 2013 Mar;61(2):144-50
pubmed: 23344773
Ann Surg. 2018 Aug;268(2):254-259
pubmed: 28628562

Auteurs

Shota Mitsuboshi (S)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Takako Matsumoto (T)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. matsumoto.takako@twmu.ac.jp.

Motoka Omata (M)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Hiroaki Shidei (H)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Akira Ogihara (A)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Akihiro Koen (A)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Hiroe Aoshima (H)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Tamami Isaka (T)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Masato Kanzaki (M)

The Department of Thoracic Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH